ARCHIVES

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Forms Task Force To Examine Marin County Breast Cancer Incidence

November 15, 2002

Foti Receives Del Duca Award; Wake Forest To Hire 60 Faculty.

February 11, 2000

Drug Shortages: Institutions Report Halting Enrollment in Clinical Trials

March 22, 2013

FDA Urges Lower Target for ESA Use; Market Could Drop By More Than Half.

March 16, 2007

Wichita CCOP Stopped Accrual For Two Months, PI Says.

May 12, 2006

CALG Loses Pediatrics Grant

July 20, 1979